Novavax Inc. Stock Rallies 10.2%, Outperforms Peers
Dow Jones2026/11/06 21:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Novavax Inc. surged 10.2% to $10.78 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 24,579.42 and the Dow Jones Industrial Average falling 0.5% to 51,285.73.
Novavax Inc. closed 19.5% below its 52-week high of $13.39, which the company reached on October 5th.
The stock outperformed some of its peers, as Johnson & Johnson rose 1.4% to $276.22, Pfizer Inc. fell 0.2% to $29.39, and Merck & Co. Inc. fell 0.14% to $146.73.
Trading volume totaled 6.3 million, compared to the 50-day average of 6.9 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 06, 2026 16:33 ET (21:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

TEM up 10.5% in the past 24 hours

Greenbriar Names Jeffrey Ciachurski Executive Chairman
Updated: Zura Bio's mid-stage clinical trial for skin disease drug fails
